Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Return to: PBR Home | Production & Manufacturing
Today in Production & Manufacturing

Production & Manufacturing

Mylan offers to buy Meda for $7.2bn Generic drug maker Mylan has agreed to acquire Swedish specialty pharmaceutical firm Meda Aktiebolag in a $7.2bn cash-and-stock transaction. Production & Manufacturing > Manufacturing > News

Latest Production & Manufacturing News by Sector

Select a sector from the list or browse by sector below:

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses
Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
Production & Manufacturing > Fine & Speciality Chemicals > News
CordenPharma agrees to purchase Peptisyntha from Solvay
By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News

Process & Production

EMA accepts Sandoz application for biosimilar to Amgen's Neulasta cancer drug
By PBR Staff Writer
The European Medicines Agency (EMA) has accepted an application to review Sandoz's biosimilar to Amgen's EU-licensed Neulasta (pegfilgrastim) cancer drug.
Production & Manufacturing > Process & Production > News
Arch Biopartners submits AB569 orphan drug application to EMA
Arch Biopartners has submitted an application for orphan drug designation to the European Medicines Authority (EMA) for AB569 in the treatment of Pseudomonas aeruginosa (P. aeruginosa) pulmonary infections in patients with cystic fibrosis.
Production & Manufacturing > Process & Production > News

OTC

Perrigo acquires generic Retin-A portfolio from Matawan Pharmaceuticals
Perrigo has completed the previously announced acquisition of a portfolio of generic dosage forms and strengths of Retin-A (tretinoin) from Matawan Pharmaceuticals.
Production & Manufacturing > OTC > News
Perrigo to buy Retin-A portfolio from Matawan Pharmaceuticals
Perrigo will acquire a portfolio of generic dosage forms and strengths of Retin-A (tretinoin) from Matawan Pharmaceuticals.
Production & Manufacturing > OTC > News

Manufacturing

Lonza, Renova sign manufacturing deal for clinical supply of RT-100 gene therapy
Lonza Houston and Renova Therapeutics have entered into a Manufacturing Services Agreement to develop a scalable manufacturing process and produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product for use in Renova’s future clinical trials.
Production & Manufacturing > Manufacturing > News
Mylan offers to buy Meda for $7.2bn
By PBR Staff Writer
Generic drug maker Mylan has agreed to acquire Swedish specialty pharmaceutical firm Meda Aktiebolag in a $7.2bn cash-and-stock transaction.
Production & Manufacturing > Manufacturing > News